Perinatal Outcomes Following Intravenous Iron for Treatment of Iron Deficiency With and Without Anemia.

anemia intravenous iron iron iron deficiency maternal iron deficiency pregnancy

Journal

European journal of haematology
ISSN: 1600-0609
Titre abrégé: Eur J Haematol
Pays: England
ID NLM: 8703985

Informations de publication

Date de publication:
03 Sep 2024
Historique:
revised: 10 08 2024
received: 01 06 2024
accepted: 12 08 2024
medline: 3 9 2024
pubmed: 3 9 2024
entrez: 3 9 2024
Statut: aheadofprint

Résumé

To determine maternal and neonatal outcomes in individuals with iron deficiency receiving antepartum intravenous (IV) iron supplementation, stratified by the degree of anemia. Retrospective cohort study of iron-deficient pregnant patients who received at least one IV infusion of iron (iron sucrose, low molecular weight iron dextran [LMWID], or ferric carboxymaltose) during their pregnancy from January 1, 2011 through June 16, 2022. Our primary outcomes included both neonatal composite morbidity and maternal composite morbidity in the context of maternal anemia. Patients who received LMWID had fewer infusion visits, received higher total doses of iron and had a more substantial correction of hemoglobin compared to those who received iron sucrose (p < 0.01). Maternal anemia at the time of admission was not associated with neonatal composite morbidity. However, there was a significant association between anemia status and maternal composite outcome (p = 0.05). Anemia at time of delivery was associated with the likelihood of requiring a blood transfusion (p = 0.01). This study reinforces previous findings emphasizing the adverse effects of iron deficiency on maternal health and the role of IV iron in reducing these risks.

Identifiants

pubmed: 39223998
doi: 10.1111/ejh.14298
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NHLBI NIH HHS
ID : R01HL151367
Pays : United States
Organisme : NIDA NIH HHS
ID : P51-OD-011092
Pays : United States
Organisme : NIDA NIH HHS
ID : DP1 DA056793
Pays : United States
Organisme : Silver Family Foundation
Organisme : American Society of Hematology

Informations de copyright

© 2024 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

K. O. Osungbade and A. O. Oladunjoye, “Preventive Treatments of Iron Deficiency Anaemia in Pregnancy: A Review of Their Effectiveness and Implications for Health System Strengthening,” Journal of Pregnancy 2012 (2012): 454601.
A. R. Zamani, Z. Farajzadegan, A. Ghahiri, M. Khademlou, and P. Golshiri, “Effectiveness of Twice Weekly Iron Supplementation Compared With Daily Regimen in Reducing Anemia and Iron Deficiency During Pregnancy: A Randomized Trial in Iran,” Journal of Research in Medical Sciences 13, no. 5 (2008): 230–239.
A. C. Weyand, A. Chaitoff, G. L. Freed, M. Sholzberg, S. W. Choi, and P. T. McGann, “Prevalence of Iron Deficiency and Iron‐Deficiency Anemia in US Females Aged 12–21 Years, 2003–2020,” Journal of the American Medical Association 329, no. 24 (2023): 2191–2193.
A. I. Lee and M. M. Okam, “Anemia in Pregnancy,” Hematology/Oncology Clinics of North America 25, no. 2 (2011): 241–259, vii.
A. E. Benson, J. J. Shatzel, K. S. Ryan, et al., “The Incidence, Complications, and Treatment of Iron Deficiency in Pregnancy,” European Journal of Haematology 109, no. 6 (2022): 633–642.
S. E. Juul, R. J. Derman, and M. Auerbach, “Perinatal Iron Deficiency: Implications for Mothers and Infants,” Neonatology 115, no. 3 (2019): 269–274.
P. J. Aggett, “Trace Elements of the Micropremie,” Clinics in Perinatology 27, no. 1 (2000): 119–129, vi.
L. Blayney, R. Bailey‐Wood, A. Jacobs, A. Henderson, and J. Muir, “The Effects of Iron Deficiency on the Respiratory Function and Cytochrome Content of Rat Heart Mitochondria,” Circulation Research 39, no. 5 (1976): 744–748.
S. F. Guiang, 3rd, J. R. Merchant, M. A. Eaton, K. B. Fandel, and M. K. Georgieff, “Intracardiac Iron Distribution in Newborn Guinea Pigs Following Isolated and Combined Fetal Hypoxemia and Fetal Iron Deficiency,” Canadian Journal of Physiology and Pharmacology 76, no. 9 (1998): 930–936.
M. Berant, M. Khourie, and I. S. Menzies, “Effect of Iron Deficiency on Small Intestinal Permeability in Infants and Young Children,” Journal of Pediatric Gastroenterology and Nutrition 14, no. 1 (1992): 17–20.
J. C. Jaime‐Perez, J. L. Herrera‐Garza, and D. Gomez‐Almaguer, “Sub‐Optimal Fetal Iron Acquisition Under a Maternal Environment,” Archives of Medical Research 36, no. 5 (2005): 598–602.
B. Mackler, R. Grace, and C. A. Finch, “Iron Deficiency in the Rat: Effects on Oxidative Metabolism in Distinct Types of Skeletal Muscle,” Pediatric Research 18, no. 6 (1984): 499–500.
F. A. Kanu, H. C. Hamner, K. S. Scanlon, and A. J. Sharma, “Anemia Among Pregnant Women Participating in the Special Supplemental Nutrition Program for Women, Infants, and Children—United States, 2008–2018,” Morbidity and Mortality Weekly Report 71, no. 25 (2022): 813–819.
WHO/UNICEF/UNU, Iron Deficiency Anaemia Assessment, Prevention, and Control: A Guide for Programme Managers (Geneva, Switzerland: World Health Organization, 2001), accessed February 27, 2023, http://www.who.int/nutrition/publications/en/ida_assessment_prevention_control.pdf.
S. Pavord, B. Myers, S. Robinson, S. Allard, J. Strong, and C. Oppenheimer, “UK Guidelines on the Management of Iron Deficiency in Pregnancy,” British Journal of Haematology 156, no. 5 (2012): 588–600.
A. Koulaouzidis, R. Cottier, S. Bhat, E. Said, B. D. Linaker, and A. A. Saeed, “A Ferritin Level >50 microg/L Is Frequently Consistent With Iron Deficiency,” European Journal of Internal Medicine 20, no. 2 (2009): 168–170.
N. R. van den Broek, E. A. Letsky, S. A. White, and A. Shenkin, “Iron Status in Pregnant Women: Which Measurements Are Valid?” British Journal of Haematology 103, no. 3 (1998): 817–824.
M. H. Seid, R. J. Derman, J. B. Baker, W. Banach, C. Goldberg, and R. Rogers, “Ferric Carboxymaltose Injection in the Treatment of Postpartum Iron Deficiency Anemia: A Randomized Controlled Clinical Trial,” American Journal of Obstetrics and Gynecology 199, no. 4 (2008): 435.e1–437.e1.
J. Daru, J. Allotey, J. P. Peña‐Rosas, and K. S. Khan, “Serum Ferritin Thresholds for the Diagnosis of Iron Deficiency in Pregnancy: A Systematic Review,” Transfusion Medicine 27, no. 3 (2017): 167–174.
World Health Organization, Nutritional Anaemias: Tools for Effective Prevention and Control (Geneva, Switzerland: World Health Organization, 2017).
“Anemia in Pregnancy: ACOG Practice Bulletin, Number 233,” Obstetrics and Gynecology 138, no. 2 (2021): e55–e64.
A. L. Siu, “Screening for Iron Deficiency Anemia and Iron Supplementation in Pregnant Women to Improve Maternal Health and Birth Outcomes: U.S. Preventive Services Task Force Recommendation Statement,” Annals of Internal Medicine 163, no. 7 (2015): 529–536.
L. A. Dickason and M. J. Dinsmoor, “Red Blood Cell Transfusion and Cesarean Section,” American Journal of Obstetrics and Gynecology 167, no. 2 (1992): 327–330; discussion 330–322.
J. O. Lo, A. E. Benson, K. L. Martens, et al., “The Role of Oral Iron in the Treatment of Adults With Iron Deficiency,” European Journal of Haematology 110, no. 2 (2023): 123–130.
S. B. Neogi, N. Devasenapathy, R. Singh, et al., “Safety and Effectiveness of Intravenous Iron Sucrose Versus Standard Oral Iron Therapy in Pregnant Women With Moderate‐to‐Severe Anaemia in India: A Multicentre, Open‐Label, Phase 3, Randomised, Controlled Trial,” Lancet Global Health 7, no. 12 (2019): e1706–e1716.
L. Wong, S. Smith, M. Gilstrop, et al., “Safety and Efficacy of Rapid (1,000 mg in 1 hr) Intravenous Iron Dextran for Treatment of Maternal Iron Deficient Anemia of Pregnancy,” American Journal of Hematology 91, no. 6 (2016): 590–593.
K. N. Varde, “Treatment of 300 Cases of Iron Deficiency of Pregnancy by Total Dose Infusion of Iron‐Dextran Complex,” Journal of Obstetrics and Gynaecology of the British Commonwealth 71 (1964): 919–922.
A. H. Arastu, B. K. Elstrott, K. L. Martens, et al., “Analysis of Adverse Events and Intravenous Iron Infusion Formulations in Adults With and Without Prior Infusion Reactions,” JAMA Network Open 5, no. 3 (2022): e224488.
C. Smith, F. Teng, E. Branch, S. Chu, and K. S. Joseph, “Maternal and Perinatal Morbidity and Mortality Associated With Anemia in Pregnancy,” Obstetrics and Gynecology 134, no. 6 (2019): 1234–1244.
J. Daru, J. Zamora, B. M. Fernández‐Félix, et al., “Risk of Maternal Mortality in Women With Severe Anaemia During Pregnancy and Post Partum: A Multilevel Analysis,” Lancet Global Health 6, no. 5 (2018): e548–e554.
L. Drukker, Y. Hants, R. Farkash, R. Ruchlemer, A. Samueloff, and S. Grisaru‐Granovsky, “Iron Deficiency Anemia at Admission for Labor and Delivery Is Associated With an Increased Risk for Cesarean Section and Adverse Maternal and Neonatal Outcomes,” Transfusion 55, no. 12 (2015): 2799–2806.
W. V. Johnson, A. H. Blaes, C. M. Booth, I. Ganguli, and A. Gupta, “The Unequal Burden of Time Toxicity,” Trends Cancer 9, no. 5 (2023): 373–375.
J. A. Kavle, R. J. Stoltzfus, F. Witter, J. M. Tielsch, S. S. Khalfan, and L. E. Caulfield, “Association Between Anaemia During Pregnancy and Blood Loss at and After Delivery Among Women With Vaginal Births in Pemba Island, Zanzibar, Tanzania,” Journal of Health, Population and Nutrition 26, no. 2 (2008): 232–240.
M. O. Omotayo, A. I. Abioye, M. Kuyebi, and A. C. Eke, “Prenatal Anemia and Postpartum Hemorrhage Risk: A Systematic Review and Meta‐Analysis,” Journal of Obstetrics and Gynaecology Research 47, no. 8 (2021): 2565–2576.
B. K. Elstrott, H. H. S. Lakshmanan, A. R. Melrose, et al., “Platelet Reactivity and Platelet Count in Women With Iron Deficiency Treated With Intravenous Iron,” Research and Practice in Thrombosis and Haemostasis 6, no. 2 (2022): e12692.
B. Elstrott, L. Khan, S. Olson, V. Raghunathan, T. DeLoughery, and J. J. Shatzel, “The Role of Iron Repletion in Adult Iron Deficiency Anemia and Other Diseases,” European Journal of Haematology 104, no. 3 (2020): 153–161.
P. Vaucher, P. L. Druais, S. Waldvogel, and B. Favrat, “Effect of Iron Supplementation on Fatigue in Nonanemic Menstruating Women With Low Ferritin: A Randomized Controlled Trial,” Canadian Journal of Physiology and Pharmacology 184, no. 11 (2012): 1247–1254.

Auteurs

Kimberly S Ryan (KS)

Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon, USA.

Kylee L Martens (KL)

Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.

Bharti Garg (B)

Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon, USA.

Boris I Chobrutskiy (BI)

Department of Internal Medicine, Oregon Health & Science University, Portland, Oregon, USA.

Madeline A Hedges (MA)

Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon, USA.

Olivia L Hagen (OL)

Division of Reproductive & Developmental Sciences, Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, USA.

Jean M G Sabile (JMG)

Department of Internal Medicine, Oregon Health & Science University, Portland, Oregon, USA.

Adam K Lewkowitz (AK)

Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Brown University Warren Alpert Medical School, Providence, Rhode Island, USA.

Methodius G Tuuli (MG)

Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Brown University Warren Alpert Medical School, Providence, Rhode Island, USA.

Thomas G Deloughery (TG)

Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.

Joseph J Shatzel (JJ)

Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.

Jamie O Lo (JO)

Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon, USA.
Division of Reproductive & Developmental Sciences, Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon, USA.

Ashley E Benson (AE)

Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon, USA.

Classifications MeSH